North Carolina

BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA® and Associated Milestone Payment

RALEIGH, , Sept. 12, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that Health Canada has granted market authorization to formally transfer the Drug Identification Number (DIN) ownership…
Continue Reading »